Exparel 266 MG/20 ML vial 20ML
Ended Awarded
- Contract number
- SPE2DX25F6AAV
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Medical Supply Chain
Troop Support, Department of Defense
- Obligated
- $30,128
Award facts
- Contract value 100% obligated
- $30,127.56 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a delivery order valued at $30,127.56 on July 14, 2025, by the Defense Logistics Agency's Medical Supply Chain. The contract covers the supply of EXPAREL 266 mg/20 ml vials, a liposomal bupivacaine local anesthetic used in surgical and post-operative pain management. The delivery order is firm fixed price with an ultimate completion date of August 4, 2025, and performance will take place at the vendor's Park Ridge, Illinois facility. No set-aside designation was used for this award.
This delivery order is issued under DMS Pharmaceutical Group's larger Indefinite Delivery Contract with the Defense Logistics Agency valued at $499,999,999 through November 2026, which authorizes the issuance of firm fixed-price orders for a comprehensive range of pharmaceutical products supporting Department of Defense medical supply requirements. The company's role as a pharmaceutical wholesaler positions it as a critical supplier within the federal pharmaceutical supply chain, providing direct distribution of prescription drugs and specialty medications to military healthcare facilities nationwide. The SPE2DB program vehicle enables the Defense Logistics Agency to efficiently source specialized pharmaceutical products such as EXPAREL to support ongoing operational and medical readiness needs.
Quick answers
Who was awarded contract SPE2DX25F6AAV?
SPE2DX25F6AAV was awarded to DMS Pharmaceutical Group Inc. by Medical Supply Chain (Troop Support) on July 14, 2025.
How much is contract SPE2DX25F6AAV worth?
The government has obligated $30,128 on SPE2DX25F6AAV.
Is contract SPE2DX25F6AAV an order under another contract?
Yes. SPE2DX25F6AAV is a delivery order under SPE2DX15D9114, an indefinite delivery contract.
Was contract SPE2DX25F6AAV competed?
The extent of competition for SPE2DX25F6AAV was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award